Abstract
A new antifungal peptide designated as pomegranin, with an N-terminal sequence resembling that of rice disease resistance NB-S-LRR-like protein, was isolated from fresh pomegranate peels by ion exchange chromatography on DEAE-cellulose, affinity chromatography on Affi-gel blue gel, and gel filtration by fast protein liquid chromatography on Superdex 75. Pomegranin was unadsorbed on DEAE-cellulose but adsorbed on Affi-gel blue gel. It exhibited a molecular mass of 11 kDa in both gel filtration and sodium dodecyl sulfate-polyacrylamide gel electrophoresis. It inhibited mycelial growth in the fungi Botrytis cinerea and Fusarium oxysporum with an IC50 of 2 μM and 6.1 μM, respectively. It was devoid of hemagglutinating, ribonuclease, deoxyribonuclease and protease inhibitory activities.
Keywords: antifungal peptide, pomegranate, isolation, peel
Protein & Peptide Letters
Title: Pomegranin, An Antifungal Peptide from Pomegranate Peels
Volume: 16 Issue: 1
Author(s): Guang Guo, He Xiang Wang and Tzi Bun Ng
Affiliation:
Keywords: antifungal peptide, pomegranate, isolation, peel
Abstract: A new antifungal peptide designated as pomegranin, with an N-terminal sequence resembling that of rice disease resistance NB-S-LRR-like protein, was isolated from fresh pomegranate peels by ion exchange chromatography on DEAE-cellulose, affinity chromatography on Affi-gel blue gel, and gel filtration by fast protein liquid chromatography on Superdex 75. Pomegranin was unadsorbed on DEAE-cellulose but adsorbed on Affi-gel blue gel. It exhibited a molecular mass of 11 kDa in both gel filtration and sodium dodecyl sulfate-polyacrylamide gel electrophoresis. It inhibited mycelial growth in the fungi Botrytis cinerea and Fusarium oxysporum with an IC50 of 2 μM and 6.1 μM, respectively. It was devoid of hemagglutinating, ribonuclease, deoxyribonuclease and protease inhibitory activities.
Export Options
About this article
Cite this article as:
Guo Guang, Wang Xiang He and Ng Bun Tzi, Pomegranin, An Antifungal Peptide from Pomegranate Peels, Protein & Peptide Letters 2009; 16 (1) . https://dx.doi.org/10.2174/092986609787049330
DOI https://dx.doi.org/10.2174/092986609787049330 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Study to Know the Impact of Ayurvedic Lifestyle on Dark Circles Around
Eyes
Current Traditional Medicine Macrophages and the Regulation of Self-Reactive T Cells
Current Pharmaceutical Design Review of Theoretical Studies for Prediction of Neurodegenerative Inhibitors
Mini-Reviews in Medicinal Chemistry Treatment of Chronic Migraine with Intramuscular Pericranial Injections of Onabotulinumtoxin A
Recent Patents on CNS Drug Discovery (Discontinued) Beta-Blockers: Current State of Knowledge and Perspectives
Mini-Reviews in Medicinal Chemistry Enhancing Aqueous Solubility of Ketoprofen by Fusion Technique Using Suitable Co-formers
Current Drug Therapy Effects of Hypoxia and Ischemia on MicroRNAs in the Brain
Current Medicinal Chemistry Acute Exercise Testing of COPD Patients: The Effect on Systemic Inflammatory Proteins
Current Respiratory Medicine Reviews CD26 Inhibition Enhances Perfusion Recovery in ApoE-/-Mice
Current Vascular Pharmacology ADAMTS Proteinases: Potential Therapeutic Targets?
Current Pharmaceutical Biotechnology Ovarian Stimulation: Today and Tomorrow
Current Pharmaceutical Biotechnology The Role of CD8+ T Cell Soluble Factors in Human Immunodeficiency Virus Infection
Current Medicinal Chemistry Creation of Retinal Vein Occlusion Model in Cynomolgus Monkeys and Determination of its Pathological Features
Current Neurovascular Research Recent Developments in Neurochemical Imaging in Schizophrenia: An Update
Current Medicinal Chemistry Inflammatory Basis of Atherosclerosis: Modulation by Sex Hormones
Current Pharmaceutical Design The Ability of Tolfenamic Acid to Penetrate the Brain: A Model for Testing the Brain Disposition of Candidate Alzheimers Drugs Using Multiple Platforms
Current Alzheimer Research A Systematic Review of the Potential Herbal Sources of Future Drugs Effective in Oxidant-Related Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Advances in Nanocarriers for Anticancer Drugs Delivery
Current Medicinal Chemistry Withdrawal Notice: Therapeutic Effect of Prdx1 on NAFLD Mice May be Related to the Activation of Nrf-2/HO-1 Pathway
Current Pharmaceutical Design Acute Coronary Syndromes as Auto-Inflammatory Disorders
Current Pharmaceutical Design